Paroxetine Oral Tablets (Immediate-Release)
Form: Oral Tablets (immediate-release)
Strength: 10 mg, 20 mg, 30 mg, 40 mg
Reference Brands: US: Paxil®, Pexeva®, Brisdelle®; EU: Seroxat®, ParoMerck®, Paxetin®
Category: Antipsychotropic Drugs
Paroxetine immediate-release tablets are FDA-approved in the USA for depression, panic disorder, OCD, PTSD, GAD, and social anxiety disorder. As a selective serotonin reuptake inhibitor (SSRI), it carries a Boxed Warning regarding increased risk of suicidal thoughts in adolescents and young adults. Regulatory oversight includes strict GMP compliance, labeling requirements, and pharmacovigilance obligations, including adverse event reporting. In the EU, paroxetine IR tablets are widely approved by national authorities and/or the EMA for similar indications. Regulatory submissions must include RMPs, PSURs, and quality documentation. Discover global suppliers and compliant dossiers at Pharmatradz.com.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Risperidone Long-Acting Injection
Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg vials/syringes
Form: Long-Acting Injection
Reference Brands: Risperdal Consta(US &EU)
View Details
Zuclopenthixol Ong-Acting Im Injection (Depot)
Strength: 200 mg/mL, 500 mg/mL
Form: Long-acting IM Injection (Depot)
Reference Brands: Clopixol Depot®(US)
View Details
Zuclopenthixol Short-Acting Intramuscular Injection
Strength: 50 mg/mL
Form: Short-acting Intramuscular Injection
Reference Brands: Clopixol-Acuphase®
View Details
Zuclopenthixol Tablets
Strength: 10 mg, 25 mg, 40 mg
Form: Oral Tablets
Reference Brands: Clopixol®(EU)
View Details